USD 0.17
(8.57%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 6.12 Million USD | -15.62% |
2022 | 5.74 Million USD | 70.15% |
2021 | 3.37 Million USD | 202.86% |
2020 | 1.11 Million USD | 57.23% |
2019 | 709 Thousand USD | 10.78% |
2018 | 640 Thousand USD | 79.27% |
2017 | 357 Thousand USD | 0.0% |
2014 | 154.68 Thousand USD | 75.97% |
2013 | 87.9 Thousand USD | -85.11% |
2012 | 590.21 Thousand USD | 36.23% |
2011 | 433.24 Thousand USD | 361.35% |
2010 | 93.9 Thousand USD | -52.46% |
2009 | 197.53 Thousand USD | -51.22% |
2008 | 404.92 Thousand USD | -25.36% |
2007 | 542.48 Thousand USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 1.69 Million USD | 67.91% |
2024 Q1 | 1.47 Million USD | -4.07% |
2023 FY | 4.84 Million USD | -15.62% |
2023 Q3 | 1.48 Million USD | 8.37% |
2023 Q4 | 1.54 Million USD | 3.59% |
2023 Q2 | 1.37 Million USD | 1.72% |
2023 Q1 | 1.34 Million USD | -14.3% |
2022 Q2 | 1.38 Million USD | -1.4% |
2022 Q1 | 1.4 Million USD | 12.38% |
2022 FY | 5.74 Million USD | 70.15% |
2022 Q4 | 1.57 Million USD | 14.8% |
2022 Q3 | 1.37 Million USD | -1.35% |
2021 Q2 | 713.65 Thousand USD | 53.81% |
2021 Q1 | 463.96 Thousand USD | 49.79% |
2021 FY | 3.37 Million USD | 202.86% |
2021 Q4 | 1.25 Million USD | 32.85% |
2021 Q3 | 944.19 Thousand USD | 32.31% |
2020 Q4 | 309.74 Thousand USD | 20.99% |
2020 Q2 | 262 Thousand USD | -8.71% |
2020 FY | 1.11 Million USD | 57.23% |
2020 Q1 | 287 Thousand USD | 96.58% |
2020 Q3 | 256 Thousand USD | -2.29% |
2019 Q1 | 192 Thousand USD | 81.13% |
2019 Q3 | 142 Thousand USD | -37.99% |
2019 Q4 | 146 Thousand USD | 2.82% |
2019 FY | 709 Thousand USD | 10.78% |
2019 Q2 | 229 Thousand USD | 19.27% |
2018 Q1 | 245 Thousand USD | 3983.33% |
2018 Q4 | 106 Thousand USD | -24.82% |
2018 Q3 | 141 Thousand USD | -6.0% |
2018 Q2 | 150 Thousand USD | -38.78% |
2018 FY | 640 Thousand USD | 79.27% |
2017 Q4 | 6000.00 USD | 500.0% |
2017 Q2 | 75 Thousand USD | -19.35% |
2017 Q1 | 93 Thousand USD | 0.0% |
2017 FY | 357 Thousand USD | 0.0% |
2017 Q3 | 1000.00 USD | -98.67% |
2015 Q1 | 108.25 Thousand USD | 85.68% |
2014 FY | 154.68 Thousand USD | 75.97% |
2014 Q2 | -688.09 Thousand USD | -307.97% |
2014 Q1 | 330.86 Thousand USD | 24.65% |
2014 Q4 | 58.3 Thousand USD | -49.64% |
2014 Q3 | 115.77 Thousand USD | 116.82% |
2013 Q3 | 92.38 Thousand USD | 315.76% |
2013 Q4 | 265.43 Thousand USD | 187.32% |
2013 FY | 87.9 Thousand USD | -85.11% |
2013 Q1 | 36.33 Thousand USD | 92.73% |
2013 Q2 | 22.22 Thousand USD | -38.84% |
2012 Q3 | 10.43 Thousand USD | 122.15% |
2012 Q4 | 18.85 Thousand USD | 80.73% |
2012 FY | 590.21 Thousand USD | 36.23% |
2012 Q1 | 284.94 Thousand USD | 75.11% |
2012 Q2 | -47.08 Thousand USD | -116.52% |
2011 Q3 | 187.4 Thousand USD | 527.15% |
2011 Q1 | 133.99 Thousand USD | -54.69% |
2011 Q4 | 162.72 Thousand USD | -13.17% |
2011 Q2 | -43.87 Thousand USD | -132.74% |
2011 FY | 433.24 Thousand USD | 361.35% |
2010 FY | 93.9 Thousand USD | -52.46% |
2010 Q2 | -33.61 Thousand USD | -930.64% |
2010 Q1 | 4047.00 USD | -93.59% |
2010 Q4 | 295.73 Thousand USD | 524.12% |
2010 Q3 | 47.38 Thousand USD | 240.96% |
2009 Q4 | 63.14 Thousand USD | 15.15% |
2009 FY | 197.53 Thousand USD | -51.22% |
2009 Q3 | 54.83 Thousand USD | 157.37% |
2009 Q2 | -95.58 Thousand USD | -252.14% |
2009 Q1 | 62.83 Thousand USD | -11.16% |
2008 Q4 | 70.71 Thousand USD | 14.43% |
2008 Q3 | 61.8 Thousand USD | -20.18% |
2008 Q1 | 78.54 Thousand USD | -79.29% |
2008 Q2 | 77.43 Thousand USD | -1.42% |
2008 FY | 404.92 Thousand USD | -25.36% |
2007 Q2 | -133.19 Thousand USD | -149.09% |
2007 Q3 | 130.37 Thousand USD | 197.88% |
2007 FY | 542.48 Thousand USD | 0.0% |
2007 Q4 | 379.32 Thousand USD | 190.96% |
2007 Q1 | 271.33 Thousand USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Achiko AG | 23.34 Thousand USD | -26125.92% |
Accelera Innovations, Inc | - USD | -Infinity% |
Aspyra Inc. | 3.91 Million USD | -56.324% |
Cannabis Sativa, Inc. | 773.08 Thousand USD | -691.95% |
CompuMed, Inc. | 2.88 Million USD | -112.129% |
CompuGroup Medical SE & Co. KGaA | 413.14 Million USD | 98.518% |
Cogstate Limited | 24.7 Million USD | 75.218% |
CareView Communications, Inc. | 6.53 Million USD | 6.256% |
Craneware plc | 162.19 Million USD | 96.225% |
Caduceus Software Systems Corp. | 925.07 Thousand USD | -561.832% |
Certive Solutions Inc. | 137.87 Thousand USD | -4340.638% |
Drug Free Solution, Inc. | 805.00 USD | -760451.677% |
DATATRAK International, Inc. | 5.14 Million USD | -18.941% |
Strainsforpains, Inc. | 84.11 Thousand USD | -7178.569% |
Healixa Inc. | 210.81 Thousand USD | -2804.246% |
Easy Technologies Inc. | - USD | -Infinity% |
eWellness Healthcare Corporation | - USD | -Infinity% |
Founders Bay Holdings | 12.3 Million USD | 50.236% |
Health Discovery Corporation | - USD | -Infinity% |
Healthcare Integrated Technologies, Inc. | 82.05 Thousand USD | -7361.66% |
H-Source Holdings Ltd. | - USD | -Infinity% |
InterCare DX, Inc. | -298.05 USD | 2054265.744% |
IQ-AI Limited | 614.03 Thousand USD | -897.083% |
Cannabiz Mobile, Inc. | - USD | -Infinity% |
Mednow Inc. | -858.82 Thousand USD | 812.889% |
Galileo Life Sciences, Inc. | - USD | -Infinity% |
MediXall Group, Inc. | -3.13 Million USD | 295.047% |
Mitesco, Inc. | - USD | -Infinity% |
MobileSmith, Inc. | 821.2 Thousand USD | -645.548% |
NantHealth, Inc. | 38.16 Million USD | 83.957% |
Net Medical Xpress Solutions, Inc. | -60 Thousand USD | 10304.068% |
OneLife Technologies Corp. | - USD | -Infinity% |
ORHub, Inc. | 222.9 Thousand USD | -2646.721% |
Patient Access Solutions, Inc. | 212.73 Thousand USD | -2777.952% |
Pharma-Bio Serv, Inc. | 5.06 Million USD | -20.844% |
PPJ Healthcare Enterprises, Inc. | 216.06 Thousand USD | -2733.598% |
Medical Cannabis Payment Solutions, Inc. | -21.91 Thousand USD | 28034.667% |
Renalytix Plc | 156 Thousand USD | -3824.642% |
Revium Recovery Inc. | -2000.00 USD | 306222.05% |
RYAH Group, Inc. | - USD | -Infinity% |
Carepay Inc. | 396.65 Thousand USD | -1443.537% |
Vaso Corporation | 50.59 Million USD | 87.899% |
Vynleads, Inc. | -35.57 Thousand USD | 17312.373% |